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Wnt5a stimulates chemotactic migration and
chemokine production in human neutrophils
Young Su Jung1,2, Ha Young Lee1,2, Sang Doo Kim1, Joon Seong Park3, Jung Kuk Kim4,
Pann-Ghill Suh4 and Yoe-Sik Bae1,2,5
Wnt5a is a ligand that activates the noncanonical Wnt signaling pathways (b-catenin-independent pathways). Human
neutrophils expressed several Wnt5a receptors, such as Frizzled 2, 5 and 8. Stimulation of human neutrophils with
Wnt5a caused chemotactic migration and the production of two important chemokines, CXCL8 and CCL2. CCL2 production
by Wnt5a was mediated by a pertussis toxin-sensitive G-protein-dependent pathway. Wnt5a also stimulated the
phosphorylation of three mitogen-activated protein kinases (MAPKs: ERK, p38 MAPK and JNK) and Akt. Inhibition of ERK,
p38 MAPK or JNK by specific inhibitors induced a dramatic reduction in Wnt5a-induced CCL2 production. Supernatant
collected from lipopolysaccharide-stimulated macrophages induced neutrophil chemotaxis, which was significantly inhibited by
anti-Wnt5a antibody. Our results suggested that Wnt5a may contribute to neutrophil recruitment, mediating the
inflammation response.
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INTRODUCTION
Wnts, which are secreted glycoproteins, are reported to be
important in the regulation of diverse (patho)physiological
responses, including cell migration, embryonic development
and tissue organization.1 Wnt5a, a prototype Wnt, is involved
in the inflammatory response.2 Wnt5a is reported to stimulate
the production of several important inflammatory cytokines
and chemokines, such as tumor necrosis factor-a, interleukin-6,
CCL2, CCL5 and CXCL1, in human endothelial cells, mono-
cytes and bone marrow stromal cells.3–5 Wnt5a binds to several
members of the Frizzled receptor family, including FZD2, 5
and 8.6 The signaling pathways induced by Wnt5a are mediated
by canonical (b-catennin-dependent) or noncanonical
(b-catenin-independent) pathways.1,6 Of these two signaling
pathways, the noncanonical pathway is known to have a
function in the inflammatory response induced by Wnt5a.6
Neutrophils, which are first recruited to an infected area or
injured site by a chemoattractant gradient, are important in the
regulation of the immune response, especially the innate
immune response.7,8 Various extracellular stimuli can activate
neutrophils, resulting in the production of several important
mediators: inflammatory cytokines and reactive oxygen
species.9,10 It is critical for the host defense mechanism that
circulating neutrophils are recruited into an infected or injured
area. This recruitment of neutrophils can be induced by various
chemoattractants.11 Chemoattractants, including several
chemokines that regulate the activities of neutrophils, have
received much attention over the last decade. The
chemoattractants bind to specific cell-surface receptors which
are G-protein coupled receptors and pertussis toxin (PTX)-
sensitive.12–14 Activation of the receptors elicits intracellular
Ca2þ mobilization, cell migration, secretion and production of
reactive oxygen species and/or bioactive lipid mediators.12–14
Even though neutrophils perform key functions in innate
immunity, the effect of Wnt5a on neutrophil activity has not
been studied. Here we investigated whether human neutrophils
express Wnt5a receptors, and also the function of Wnt5a in
neutrophil activity.
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MATERIALS AND METHODS
Materials
Recombinant mouse Wnt5a protein was from Millipore (Billerica,
MA, USA). Recombinant human soluble frizzled related protein-1
(sFRP1) and anti-Wnt5a antibody were obtained from R&D Systems
(Minneapolis, MN, USA). Peripheral blood mononuclear cell separa-
tion medium (Histopaque-1077) and cytochrome c were from Sigma
(St Louis, MO, USA). PTX, PD98059, SB203580, SP600125, U-73122,
U-73343 and LY294002 were from Calbiochem (San Diego, CA,
USA). BAY11-7082 was from Enzo Life Sciences (Farmingdale, NY,
USA).
Isolation of human neutrophils and monocytes
This study was approved by the Institutional Review Board of the
Ajou University Hospital specifically (approval ID: AJIRB-MED-SMP-
10-074). We also obtained written informed consent from all
participants involved in this study. Human neutrophils and mono-
cytes were isolated as described previously.15
RT-PCR Analysis
Semiquantitative RT-PCR was performed as described previously.3
The sequences of the primer used were as follows; fzd2: forward,
50-GCGTCTTCTCCGTGCTCTAC-30; reverse, 50-CTGTTGGTGAGG
CGAGTGTA-30. fzd3: forward, 50-TGAGTGTTCGAAGCTCATGGA-30;
reverse, 50-ATCACGCACATGCAGAAAAG-30. fzd4: forward, 50-AACC
TCGGCTACAACGTGAC-30; reverse, 50-GTTGTGGTCGTTCTGTGG
TG-30. fzd5: forward, 50-TGCTACCAGCCGTCCTTCAGT-30; reverse,
50-CCATGCCGAAGAAGTAGACCAG-30. fzd8: forward, 50- TCTTGT
CGCTCACATGGTTC-30; reverse, 50-TGTAGAGCACGGTGAACAGG-30.
GAPDH: forward, 50-GACATCAAGAAGGTGGTGAA-30, reverse,
50-TGTCATACCAGGAAATGAGC-30.
Chemotaxis assay
Chemotaxis assays were performed using multi-well chambers (Neu-
roprobe, Gaithersburg, MD, USA) as described previously.16 Briefly,
isolated fresh human neutrophils (25ml of 1 106 cells per ml) were
placed onto the upper well a 3-mm polyhydrocarbon filter. Various
concentrations of Wnt5a were applied into lower well. After
incubation for 90min migrated cells across the filter were counted
as described previously.16
Measurement of the formation of inositol phosphates in
cells
The formation of inositol phosphates was determined as described
previously.17 Briefly, freshly isolated human neutrophils (5 106 cells
per ml) were labeled with myo-[3H] inositol (1mCi per 106 cells) for
12 h at 371C. After stimulating labeled human neutrophils with
several concentrations of Wnt5a, ice-cold 5% perchloric acid
(HClO4) was added. Produced total inositol phosphates were
separated according to standard procedure describe previously.17
Measurement of chemokines
Human neutrophils (2 106 cells per 0.2ml) were placed in RPMI
1640 medium containing 5% FBS in 96-well plates, and were kept in a
5% CO2 incubator at 37 1C. Neutrophils were incubated with several
concentrations of Wnt5a (0.1, 0.5 or 1mgml1) for 24 h in the
presence or absence of PTX, or kinase inhibitors (PD98059, SB203580
or SP600125). Cell-free supernatants were collected, centrifuged and
measured for CXCL8 or CCL2 production by enzyme-linked immu-
nosorbent assay (CXCL8; BD Biosciences, San Jose, CA, USA, CCL2;
eBioscience, Inc., San Diego, CA, USA) according to the manufac-
turer’s instructions.
Measurement of the effect of supernatant from
lipopolysaccharide-stimulated macrophages on neutrophil
chemotaxis
Human monocytes were differentiated to macrophages by adding
M-CSF (10 ngml1) for 3 days. Macrophages were stimulated with
lipopolysaccharide (LPS; 1mgml1) for 24 h and the supernatant was
collected. Isolated human neutrophils were incubated with vehicle or
anti-Wnt5a antibody for 30min, suspended at 1 106 cells per ml,
and were used as described above for chemotaxis.
Statistical analysis
Results are expressed as mean±s.e. for data obtained from the
indicated number of experiments. Statistical significance was deter-
mined using the Student’s t-test.
RESULTS
Chemotactic effect of Wnt5a on human neutrophils
To examine whether human neutrophils express receptors for
Wnt5a, we analyzed mRNA for FZD2, 3, 4, 5 and 8 by semi-
quantitative reverse-transcription PCR. As shown in Figure 1a,
human neutrophils expressed FZD2, FZD5 and FZD8 Wnt5a
receptors.
We also investigated the effect of Wnt5a on neutrophil
chemotaxis. Wnt5a at 0.01–1mM induced migration of human
neutrophils according to concentration-response curves
(Figure 1b). This implied that Wnt5a induced chemotaxis in
human neutrophils. The chemotactic activity of Wnt5a was
comparable to the well-known chemoattractant WKYMVm.18
As sFRP1 binds to Wnt5a and blocks the action of Wnt5a to
its specific receptors,19 we examined the effect of sFRP1
on Wnt5a-induced human neutrophil chemotaxis. As
shown in Figure 1c, Wnt5a-stimulated chemotaxis of neutro-
phil was almost completely inhibited by sFRP1. However,
WKYMVm-induced neutrophil chemotaxis was not inhibited
by sFRP1 (data not shown). This result indicated that Wnt5a
stimulated neutrophil chemotaxis via specific receptors in the
FZD family.
Wnt5a-stimulated neutrophil chemotaxis is mediated by
phospholipase C activity
As many frizzled receptors, including FZD2, FZD5 and FZD8,
have been reported as G-protein-coupled receptors,20 and
many G-protein-coupled receptors can induce the stimu-
lation of phospholipase C (PLC) upon ligand binding, we
tested the effect of Wnt5a on PLC activity in human
neutrophils. Stimulation of human neutrophils by several
different concentrations of Wnt5a elicited an increase in
total inositol phosphate formation. This showed a
concentration dependency (Figure 2a). These results indicated
that Wnt5a stimulated PLC activity in human neutrophils. As
Wnt5a stimulated neutrophil chemotaxis, we examined the
role of PLC on Wnt5a-stimulated chemotaxis. Preincubation
of human neutrophils with a PLC-selective inhibitor
(U-73122) before chemotaxis assay almost completely
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inhibited Wnt5a-induced neutrophil chemotaxis (Figure 2b).
An inactive analog of U-73122, U-73343, did not inhibit
Wnt5a-induced chemotaxis. These results indicated
that Wnt5a-stimulated neutrophil chemotaxis was mediated
by PLC.
Wnt5a-stimulated neutrophil chemotaxis is mediated by
phosphoinositide 3-kinase activity
We also tested the effect of Wnt5a on the important signaling
molecules mitogen-activated protein kinases (MAPKs) and
Akt. Stimulation of human neutrophils with Wnt5a for several
different lengths of time caused phosphorylation of ERK, p38
MAPK, JNK and Akt (Figure 3a). Phosphorylation of Akt and
ERK was apparent within 2–10min after Wnt5a stimulation,
and phosphorylation of p38 MAPK was sustained from 2 to
30min after Wnt5a stimulation (Figure 3a). Wn5a transiently
stimulated phosphorylation of JNK in human neutrophils at
2min after stimulation (Figure 3a). ATF2 phosphorylation was
also induced by Wnt5a, and its phosphorylation was sustained
to 30min after stimulation (Figure 3a).
We also investigated the role of signaling pathways in the
activation of MAPKs and Akt on Wnt5a-stimulated neutrophil
chemotaxis, using several inhibitors that are specific for ERK,
p38 MAPK, JNK or phosphoinositide 3-kinase (an upstream
kinase of Akt). As shown in Figure 3b, Wnt5a-stimulated
neutrophil chemotaxis was almost completely inhibited by
LY294002 (a phosphoinositide 3-kinase inhibitor), but not by
other MAPK inhibitors. These results indicated that the
phosphoinositide 3-kinase activity was essential for neutrophil
chemotaxis induced by Wnt5a.
Wnt5a stimulates CXCL8 production via ERK and p38
MAPK pathway in human neutrophils
Human neutrophils produce the important chemokine CXCL8
that recruits several important human leukocytes, including
neutrophils.21 We measured the effect of Wnt5a on the
production of CXCL8 in human neutrophils. Stimulation of
human neutrophils with several concentrations of Wnt5a
elicited the production of CXCL8 in a concentration-
dependent manner, showing maximal activity at 1mgml1
Wnt5a (Figure 4a). We also tested the effect of Wnt5a on
the production of CXCL8 for various lengths of time.
Stimulation of human neutrophils with 1mgml1 Wnt5a
elicited the production of CXCL8 in a time-dependent
manner, with maximal activity at 12 h after stimulation
(Figure 4b). We examined the effect of PTX on the
production of CXCL8 in human neutrophils after Wnt5a
treatment. CXCL8 production after Wnt5a was not affected
by PTX, but rather substantially increased by PTX
(Figure 4c). These results indicated that Wnt5a stimulated
CXCL8 production from human neutrophils via a PTX-
insensitive pathway.
The activation of transcription factors, such as nuclear
factor-kB (NF-kB) is known to be required for the expression
of chemokines, including CXCL8 and CCL2.21,22 We
investigated the effect of Wnt5a on NF-kB activation, and
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Figure 1 Expression of Wnt5a receptors in human neutrophils and chemotactic activity of Wnt5a on human neutrophils. mRNA was
isolated from human neutrophils or human mesenchymal stem cells. Semiquantitative reverse-transcription PCR determined fzd2, fzd3,
fzd4, fzd5 and fzd8 mRNAs. Data are representative of three independent experiments (a). Assays were performed using a modified
Boyden chamber assay. Isolated human neutrophils (1106 cells per ml in serum-free RPMI 1640 medium) were added to the upper
wells of a 96-well chemotaxis chamber and migration across a polycarbonate membrane with 3mm pore size was assessed after 1.5h at
37 1C (b). Human neutrophils were incubated with or without 1mgml1 of sFRP1 for 30min. Cells were used in a chemotaxis assay
using 1mgml1 of Wnt5a (c). Migrated cells were determined by counting under light microscope. Data are mean±s.e.; n¼6, *Po0.05,
**Po0.01 versus vehicle treatment.
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also tested the role of MAPK pathways on Wnt5a-stimulated
CXCL8 production in human neutrophils. Wnt5a-induced
CXCL8 production was inhibited by SB203580 (a p38 MAPK
inhibitor), but not by PD98059 (an ERK pathway inhibitor),
indicating that p38 MAPK activity was involved in Wnt5a-
stimulated CXCL8 production. Preincubation of neutrophils
with SP600125 (a JNK inhibitor) before Wnt5a stimulation
elicited increased production of CXCL8 (Figure 4d). We also
tested the role of NF-kB on the production of CXCL8 induced
by Wnt5a, using an NF-kB-selective inhibitor (BAY11-7082).
Preincubation of human neutrophils with BAY11-7082 before
addition of Wnt5a markedly increased Wnt5a-induced CXCL8
production (Figure 4d).
Wnt5a-stimulated CCL2 production is mediated by a PTX-
sensitive G-protein, JNK and NF-kB in human neutrophils
Another important chemokine, CCL2, recruits some leuko-
cytes, including monocytes, and is produced by human
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Figure 2 Effect of Wnt5a on PLC activity and neutrophil chemotaxis. Human neutrophils were labeled with myo-[3H] inositol (1mCi per
106 cells) for 12h at 37 1C, and were treated with various concentrations of Wnt5a (0, 0.1, 0.5 and 1mM) or WKYMVm (1mM). Total
inositol phosphates were eluted with a solution containing 1M ammonium formate and 0.1M formic acid. [3H]-inositol phosphates were
counted in a scintillation counter (a). Human neutrophils were incubated with or without U-73122 (5mM) or U-73343 (5mM) for 15min.
Cells were used for a chemotaxis assay using 1mgml1 of Wnt5a (b). Migrated cells were determined by counting under light
microscope. Data are mean±s.e.; n¼6, *Po0.05, **Po0.01, ***Po0.001 versus vehicle treatment.
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Figure 3 Effect of Wnt5a on MAPKs, Akt and ATF2 activity, and neutrophil chemotaxis. Isolated human neutrophils were stimulated with
1mgml1 Wnt5a for 0, 2, 5, 10 or 30min, then 30mg of cell lysates were subjected to SDS-polyacrylamide gel electrophoresis, followed
by immunoblot analysis using anti-phospho-ERK, anti-phospho-p38 MAPK, anti-phospho-JNK, anti-phospho-Akt or anti-phospho-ATF2.
Western blots were performed with anti-actin to confirm sample loading. Data are representative of three independent experiments (a).
Human neutrophils were incubated with or without PD98059 (50mM), SB203580 (20mM), SP600125 (20mM) or LY294002 (5mM) for
15min (60min for PD98059). Cells were used for chemotaxis assays using 1mgml1 of Wnt5a (b). Migrated cells were determined by
counting under light microscope. Data are mean±s.e.; n¼5, **Po0.01, ***Po0.001.
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neutrophils in response to extracellular stimuli.23 We examined
the effect of Wnt5a on the production of CCL2 in human
neutrophils. Stimulation of human neutrophils with
several concentrations of Wnt5a elicited the production of
CCL2 in a concentration-dependent manner, showing
maximal activity at 1mgml1 Wnt5a (Figure 5a). We also
tested the effect of Wnt5a on the production of CCL2
for various lengths of time. Stimulation of human
neutrophils with 1mgml1 Wnt5a elicited the production of
CCL2 in a time-dependent manner, with maximal activity at
12 h after stimulation (Figure 5b). For PTX sensitivity, CCL2
production by Wnt5a was completely affected by PTX
(Figure 5c). These results indicated that Wnt5a stimulated
CCL2 production from human neutrophils via PTX-sensitive
pathway. We also tested the function of several MAPK
pathways on Wnt5a-stimulated CCL2 production in human
neutrophils. Wnt5a-induced CCL2 production was
inhibited by SB203580 (a p38 MAPK inhibitor), PD98059
(an ERK pathway inhibitor) and SP600125 (a JNK inhibitor),
indicating that all the three MAPK activities were involved in
Wnt5a-stimulated CCL2 production. We also tested the
role of NF-kB on the production of CXCL8 induced by Wnt5a
using the NF-kB-selective inhibitor BAY11-7082. Preincuba-
tion of human neutrophils with BAY11-7082 before addition
of Wnt5a strongly inhibited Wnt5a-induced CCL2
production.
Macrophage conditioned medium stimulated with LPS
induces neutrophil chemotactic migration
According to previous reports, Wnt5a is produced mainly by
stimulated macrophages.2,3 Activated macrophages secrete
various soluble factors, which in turn induce migration of
other leukocytes, including through several chemoattra-
ctants.24 We demonstrated that Wnt5a stimulated human
neutrophil chemotactic migration (Figure 1). Previously it
has been reported that activation of macrophages by LPS
enhances the expression of Wnt5a in mRNA and protein
levels.25 To test the hypothesis that LPS stimulated
macrophages to produce Wnt5a-mediating neutrophil
chemotaxis, we examined the effect of chemotactic migration
by neutrophils induced by supernatant from LPS-stimulated
macrophages. Neutrophil chemotaxis was strongly induced
by LPS-stimulated macrophage supernatant (Figure 6).
This was significantly inhibited by anti-Wnt5a antibody.
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Figure 4 Effect of Wnt5a on CXCL8 production in human neutrophils. Isolated human neutrophils were stimulated with several
concentrations of Wnt5a for 24h (a) or with 1mgml1 of Wnt5a for different times (b). Neutrophils were preincubated with or without
1mgml1 of PTX for 4h then stimulated with 1mgml1 of Wnt5a for 24h (c). Human neutrophils were incubated with or without
PD98059 (50mM), SB203580 (20mM), SP600125 (20mM) or BAY11-7082 (5mM) for 15min (60min for PD98059). Cells were
stimulated with 1mgml1 of Wnt5a for 24h (d). Supernatants were collected from cultures and evaluated for CXCL8 (a–d) production by
enzyme-linked immunosorbent assay. Data are means±s.e.; n¼6, **Po0.01, ***Po0.001 versus vehicle treatment; #Po0.05 versus
dimethylsulfoxide plus Wnt5a-treated control.
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We confirmed that anti-Wnt5a antibody strongly inhibited
Wnt5a-stimulated neutrophil chemotaxis (data not shown).
We also tested direct effect of LPS on neutrophil chemotaxis;
LPS itself could not induce neutrophil chemotaxis (data not
shown).
DISCUSSION
As neutrophils are important in human early defense
activity,7–10 the identification of endogenous molecules that
regulate neutrophil function is of paramount importance. In
this study we demonstrated that Wnt5a, an endogenous
glycoprotein secreted from stimulated macrophages, stimu-
lated neutrophil activity. Functionally, we found that Wnt5a
stimulated neutrophil chemotaxis and chemokine production.
However, Wnt5a failed to stimulate superoxide anion
production from human neutrophils (data not shown). Since
superoxide anion production is required for killing invading
pathogens, Wnt5a might not stimulate the bactericidal activity
of neutrophils against pathogens. As Wnt5a stimulated the
production of two important chemokines, CXCL8 and CCL2,
which are potent chemoattractants for neutrophils and
monocytes, Wnt5a might regulate the immune response by
inducing leukocyte migration.
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Figure 5 Effect of Wnt5a on CCL2 production from human neutrophils. Isolated human neutrophils were stimulated with several
concentrations of Wnt5a for 24h (a) or with 1mgml1 of Wnt5a for different times (b). Neutrophils were preincubated with or without
1mgml1 of PTX for 4h and stimulated with 1mgml1 of Wnt5a for 24h (c). Human neutrophils were incubated with or without
PD98059 (50mM), SB203580 (20mM), SP600125 (20mM) or BAY11-7082 (5mM) for 15min (60min for PD98059). Cells were
stimulated with 1mgml1 of Wnt5a for 24h (d). Supernatants were collected from cultures and were evaluated for CCL2 (a–d)
production by enzyme-linked immunosorbent assay. Data are means±s.e.; n¼6, *Po0.05, **Po0.01, ***Po0.001 versus vehicle
treatment; #Po0.05 versus dimethylsulfoxide plus Wnt5a-treated control.
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Figure 6 Role of Wnt5a on the chemotactic migration of neutro-
phils induced by supernatant from LPS-stimulated macrophages.
Human macrophages were stimulated with LPS (1mgml1) for
24h, and supernatant was collected. Freshly isolated human
neutrophils were used for a chemotaxis assay using supernatant
from LPS-stimulated macrophages in the absence or presence of
anti-Wnt5a antibody (2mgml1) for 1.5h. Migrated cells were
determined by counting under light microscope. Data are
mean±s.e.; n¼4, *Po0.05, ***Po0.001.
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We demonstrated that Wnt5a stimulated the production of
two important chemokines, CXCL8 and CCL2 (Figures 4, 5).
To identify the signaling pathways involved in the Wnt5a-
stimulated chemokine production, we found that production
of CCL2 induced by Wnt5a, but not by CXCL8, was
completely inhibited by PTX (Figures 4, 5). These results
indicated that a PTX-sensitive G-protein-mediated pathway
was necessary for Wnt5a-stimulated production of CCL2,
but not CXCL8. As FZD2, a receptor for Wnt5a, signaling
is known to be mediated by PTX-sensitive G-proteins,26
our results support the hypothesis that Wnt5a may
stimulate FZD2, which is coupled to PTX-sensitive
G-proteins, thus resulting in CCL2 expression. In addition,
JNK and NF-kB activities were required for Wnt5a-stimulated
production of CCL2 but not CXCL8. Taken together, our
results suggested that Wnt5a stimulated CCL2 via a
PTX-sensitive G-protein, JNK and the NF-kB pathway.
However, Wnt5a-stimulated CXCL8 production used a
signaling pathway independent of a PTX-sensitive G-protein,
JNK and NF-kB. As the Wnt5a-induced CXCL8 production
was mediated by p38 MAPK (Figure 4d), which stimulates
ATF-2 activity, ATF-2 activity may be involved in Wnt5a-
induced CXCL8 production.
The activation of macrophages by LPS has been known to
enhance the expression of Wnt5a25. To understand the
functional role of Wnt5a in vivo, we examined the effect of
supernatant from LPS-stimulated macrophages on neutrophil
chemotaxis. We found that the effect of supernatant collected
from macrophages stimulated with LPS was significantly
inhibited by anti-Wnt5a antibody (Figure 6). From these
results, we suggest that Wnt5a may be secreted from activated
macrophages with LPS and strongly induces neutrophil
chemotaxis. In addition, Wnt5a stimulated secretion of
CXCL8 and CCL2 (Figures 4, 5), which are potent chemoat-
tactants for neutrophils and monocytes, respectively.27,28 Taken
together, these results suggested that Wnt5a may mediate an
important positive loop for the recruitment of neutrophils,
monocytes and macrophages into event area in response to
infection.
Previously, Lee and colleagues3 demonstrated that Wnt5a
stimulates endothelial cells, resulting in the expression of
several important inflammatory molecules, such as COX-2,
CXCL8, CX3CL1 and E-selectin. In this study we showed that
Wnt5a stimulated neutrophils, resulting in chemotactic mig-
ration and expression of two important chemokines (CXCL8
and CCL2). The previous reports and our findings suggested
that Wnt5a might induce inflammatory responses by
modulating not only endothelial cell activity but also
neutrophil activity. A b-catenin-independent signaling
pathway mediated this Wnt5a-induced inflammatory
response in neutrophils as well as in endothelial cells.
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